191.035 articles found

Re: Assessing the Association Between Gadolinium-based Contrast Agents and Parkinson Disease: Insights from the Korean National Health Insurance Service Database.

Moon WJ, Bae YJ, Kim JM.

Invest Radiol · 2025-04-02

DOI: 10.1097/rli.0000000000001183PMID: 40173417

LRRK2 Mediates α-Synuclein-Induced Neuroinflammation and Ferroptosis through the p62-Keap1-Nrf2 Pathway in Parkinson's Disease.

Liu X, Zheng Z, Xue C, Wang X, Li J, Liu Z, Xin W, Xu X, Zhou D, Yao L, Lu G.

Inflammation · 2025-04-02

DOI: 10.1007/s10753-025-02291-8PMID: 40169487

Translating Brain Anatomy and Disease from Mouse to Human in Latent Gene Expression Space

Jaroszynski C, Amer M, Beauchamp A, Lerch JP, Sotiropoulos SN, Mars RB.

· 2025-04-01

DOI: 10.1101/2025.03.31.646307

Human mitochondrial ferritin exhibits highly unusual iron-O ₂ chemistry distinct from that of cytosolic ferritins

Bradley JM, Bugg Z, Pullin J, Moore GR, Svistunenko DA, Le Brun NE.

· 2025-04-01

DOI: 10.1101/2025.03.31.646379

Structural defects in amyloid-β fibrils drive secondary nucleation

Hu J, Scheidt TJ, Thacker D, Axell E, Stemme E, Lapinska U, Wennmalm S, Meisl G, Curk S, Andreasen M, Vendruscolo M, Arosio P, Saric A, Schmit J, Knowles T, Sparr E, Linse S, Michaels TCT, Dear AJ.

· 2025-04-01

DOI: 10.1101/2025.03.31.646415

Localization of accessory pathways in Wolff‐Parkinson‐white syndrome using ECG‐based multi‐task deep learning

Hennecken J, Arends B, Mast T, Dekker L, van der Harst P, Blaauw Y, Dichtl W, Senoner T, Hassink R, Loh P, van Es R, van de Leur R.

European journal of clinical investigation · 2025-04-01

Advances in Research on Exosomal miRNAs in Central Nervous System Diseases.

Feng G, Lan X, Qin S, Shi Y, Zhao Q, Li Q, Zhong L.

ASN Neuro · 2025-04-01

DOI: 10.1080/17590914.2025.2465546PMID: 40165664

Enhancing multi-class neurodegenerative disease classification using deep learning and explainable local interpretable model-agnostic explanations.

Baili J, Alqahtani A, Almadhor A, Al Hejaili A, Kim TH.

Front Med (Lausanne) · 2025-04-01

DOI: 10.3389/fmed.2025.1562629PMID: 40236458

Corrigendum: The effects of chemogenetic targeting of serotonin-projecting pathways on L-DOPA-induced dyskinesia and psychosis in a bilateral rat model of Parkinson's disease.

Lipari N, Galfano A, Venkatesh S, Grezenko H, Sandoval IM, Manfredsson FP, Bishop C.

Front Neural Circuits · 2025-04-01

DOI: 10.3389/fncir.2025.1593235PMID: 40236617

Intrastriatal injection of alpha-synuclein preformed fibrils to rats results in L-DOPA reversible sensorimotor impairments and alterations in non-motor function.

Fleming SM, Scott S, Hamad EJ, Herman DE, Holden JG, Yan L, Linning-Duffy K, Kemp CJ, Patterson JR, Miller KM, Kubik M, Kuhn N, Stoll AC, Duffy MF, Steece-Collier K, Cole-Strauss A, Lipton JW, Luk KC, Sortwell CE.

Front Neurosci · 2025-04-01

DOI: 10.3389/fnins.2025.1556447PMID: 40236948

Historical Perspectives of Parkinson's Disease: Early Clinical Descriptions and Neurological Therapies.

Goetz CG.

Cold Spring Harb Perspect Med · 2025-04-01

DOI: 10.1101/cshperspect.a041642PMID: 38858084

Integrating Mendelian Randomization With Single-Cell Sequencing Data Reveals the Causal Effect and Related Mechanisms of Smoking on Parkinson's Disease.

Zhang X, Zhu Z, Zhu L, Guan Y, Zhu Z, Liu B, Ren H, Yang X.

Nicotine Tob Res · 2025-04-01

DOI: 10.1093/ntr/ntae180PMID: 39030896